Orthopedic and sports medicine technology company Ortho Regenerative Technologies unveiled Claude LeDuc as its new president and CEO, according to Biospace. By Alan Condon - 6/18/19

Regenerative Medicine Minnesota is a bipartisan effort to improve research, technology, education and patient access to regenerative medicine-based treatments. By Eric Oliver - 6/17/19

Regenerative medicine has life-changing potential, but illegal actors are spurring a rash of regulatory activities. By Eric Oliver - 6/14/19

Here are four key updates in about spinal biologics companies and advancements. By Alan Condon - 6/13/19

East Bay Health and Wellness Center, which offers chiropractic and wellness services in Walnut Creek, Calif., caught the ire of local CBS affiliate KPIX 5 for the unconventional way it markets unproven stem cell treatments. By Eric Oliver - 6/13/19

NC Biomatrix BV is producing a biomaterial that will assist the treatment of intervertebral disc degeneration in a minimally invasive way, reports Innovation Origins. By Alan Condon - 6/13/19

Robert LaPrade, MD, PhD, a complex knee and sports medicine surgeon, joined Golden Valley, Minn.-based Twin Cities Orthopedics June 3.  By Eric Oliver - 6/12/19

Ottawa, Canada-based biomaterials startup Spiderwort closed a $500,000 oversubscribed friends and family funding round, reports BetaKit. By Alan Condon - 6/12/19

Orthopedic fixation company, Ossio, won the 2019 Frost & Sullivan North America New Product Innovation Award for its bone regeneration device, Ossiofiber. By Alan Condon - 6/11/19

Regenerative medicine and cell therapy company InGeneron extended its Series D financing by up to $23 million, totaling $43 million, to be invested in the company. By Alan Condon - 6/11/19

Konica Minolta Healthcare is hosting an autologous biologics workshop in collaboration with EmCyte to support education for ultrasound-guided musculoskeletal inventions. By Alan Condon - 6/10/19

Bioventus has partnered with MTF Biologics to co-develop a placental tissue product for the treatment of painful musculoskeletal conditions, focusing initially on knee osteoarthritis. By Alan Condon - 6/10/19

Selby Chen, MD, is a board-certified neurosurgeon and an assistant professor of neurosurgery at the Mayo Clinic in Jacksonville, Fla. By Alan Condon - 6/6/19

Scottsdale, Ariz.-based R3 Stem Cell responded to an FDA letter that raised safety and legality concerns over R3's stem cell offerings. By Eric Oliver - 6/6/19

A federal judge granted the FDA authority to regulate treatments from U.S. Stem Cell Clinic and U.S. Stem Inc., NBC News reports. By Eric Oliver - 6/5/19

Niagara Falls (N.Y.) Memorial Medical Center and Andrew Cappuccino, MD, of Buffalo (N.Y.) Spine Surgery are opening a stem cell therapy center, reports WNY Papers.com. By Alan Condon - 5/29/19

A new study published in The Spine Journal examines outcomes from posterior lumbar fusions at a physician-owned hospital compared with a non-physician-owned hospital.  By Laura Dyrda - 5/24/19

Atlanta-based Emory Orthopedics & Spine Center's Ken Mautner, MD, is studying how three different stem cell therapies treat osteoarthritis, local news affiliate Fox 5 reports.  By Eric Oliver - 5/23/19

A new study published in The Spine Journal examines long-term data on the risk for cancer associated with recombinant human bone morphogenetic protein use in spinal fusions. By Laura Dyrda - 5/20/19

A new study published in Spine examines 30- and 90-day readmission rates for spinal fusions. By Laura Dyrda - 5/17/19